James Xue,Founder and CEO of CANbridge,to Present at 2016 East West CEO Conference

Dec 17, 2015

CANbridge Appoints Mark A. Goldberg as Acting Chief Medical Officer Raises Additonal Capital in Series a Plus Round

Oct 22, 2015

CANbridge Acquires License for Apogenix’s APG101 Onco-immunotherapy in Glioblastoma for China

Jul 16, 2015

CANbridge Life Sciences, Inc. Joins the Medtech Group

Apr 08, 2015

CANbridge Life Sciences Ceo,James Xue, Presenting at Cancer Advanced Boston and Boston CEO

Apr 02, 2015